Organogenesis Holdings Income Statement (2015-2026) | ORGO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	123.20M	113.75M	127.86M	97.12M	121.40M	116.86M	115.52M	107.64M	117.32M	108.53M	99.65M	109.98M	130.23M	115.18M	126.66M	86.69M	101.00M	150.86M	225.61M	37.23M
Cost of Revenue (Quarter)	29.94M	26.17M	32.60M	25.08M	26.65M	26.18M	27.11M	26.61M	26.32M	25.79M	27.77M	28.70M	53.55M	48.09M	118.61M	23.72M	48.94M	53.21M	49.92M	25.77M
Gross Profit (Quarter)	93.26M	87.59M	95.26M	72.04M	94.75M	90.68M	88.41M	81.03M	91.00M	82.74M	71.88M	81.28M	101.04M	88.38M	95.61M	62.97M	52.06M	97.66M	175.69M	11.46M
Operating items
Research & Development (Quarter)	7.32M	8.95M	8.26M	8.59M	10.21M	9.57M	11.39M	11.20M	10.94M	10.47M	11.77M	12.81M	15.59M	10.34M	11.53M	10.64M	10.39M	13.22M	10.29M	15.16M
Selling, General & Administrative (Quarter)	62.35M	62.37M	67.25M	63.58M	72.61M	79.33M	68.29M	73.83M	70.32M	64.22M	61.38M	72.32M	76.54M	71.80M	1.19M	72.51M	73.81M	79.74M	100.17M	65.19M
Other Operating Expenses (Quarter)											-207.65M		-62.93M	26.80M	-263.87M	30.29M	-56.58M	-56.71M	-60.54M	25.77M
Operating Expenses (Quarter)	69.67M	71.32M	75.51M	72.17M	82.81M	88.90M	79.69M	85.04M	81.25M	74.69M	-134.50M	85.13M	29.20M	108.94M	-251.15M	113.44M	27.63M	36.25M	49.92M	106.12M
Operating Income (Quarter)	23.59M	16.26M	19.75M	-0.13M	11.94M	1.78M	8.72M	-4.00M	9.74M	8.05M	-1.27M	-3.85M	-13.89M	6.24M	10.22M	-26.75M	-12.58M	20.73M	28.46M	-68.89M
EBIT (Quarter)	23.59M	16.26M	19.75M	-0.13M	11.94M	1.78M	8.72M	-4.00M	9.74M	8.05M	-1.27M	-3.85M	-13.89M	6.24M	10.22M	-26.75M	-12.58M	20.73M	28.46M	-68.89M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	0.02M	-0.02M	-1.88M	-0.00M	-0.02M	0.01M	0.01M	0.02M	0.03M	0.03M	-0.03M	0.02M	-0.03M	0.05M	-0.03M	0.00M	0.07M	0.02M	-0.10M	0.04M
Non Operating Income (Quarter)	-2.41M	-0.02M	-9.13M	-0.00M	-0.75M	0.01M	2.04M	-0.63M	-0.57M	0.03M	-0.53M	0.02M	-0.03M	-0.42M	1.58M	0.96M	0.74M	0.43M	2.18M	0.04M
Net income details
EBT (Quarter)	21.17M	12.88M	18.89M	-0.87M	11.18M	1.21M	8.75M	-4.63M	9.18M	7.64M	-1.80M	-4.34M	-14.54M	5.82M	10.25M	-25.78M	-11.83M	21.16M	63.43M	-68.47M
Tax Provisions (Quarter)	0.49M	0.30M	-0.13M	0.04M	2.44M	1.00M	1.27M	-1.66M	3.86M	4.47M	-1.23M	-2.24M	2.50M	-6.51M	2.58M	-6.94M	-2.44M	-0.41M	10.23M	-15.32M
Profit After Tax (Quarter)	20.69M	12.58M	50.99M	-0.91M	8.74M	0.21M	7.49M	-2.97M	5.32M	3.17M	-0.57M	-2.10M	-17.04M	12.33M	7.67M	-18.84M	-9.39M	21.57M	43.70M	-53.16M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	20.69M	12.58M	19.02M	-0.91M	8.74M	0.21M	7.49M	-2.97M	5.32M	3.17M	-0.57M	-2.10M	-17.04M	12.33M	7.67M	-18.84M	-9.39M	21.57M	53.20M	-53.16M
Consolidated Net Income (Quarter)	20.69M	12.58M	19.02M	-0.91M	8.74M	0.21M	7.49M	-2.97M	5.32M	3.17M	-0.57M	-2.10M	-17.04M	12.33M	7.67M	-18.84M	-9.39M	21.57M	53.20M	-53.16M
Income towards Parent Company (Quarter)	20.69M	12.58M	19.02M	-0.91M	8.74M	0.21M	7.49M	-2.97M	5.32M	3.17M	-0.57M	-2.10M	-17.04M	12.33M	7.67M	-18.84M	-9.39M	21.57M	53.20M	-53.16M
Preferred Dividend Payments (Quarter)															0.41M	2.63M	0.13M	0.14M	0.15M	2.84M
Net Income towards Common Stockholders (Quarter)	20.69M	12.58M	19.02M	-0.91M	8.74M	0.21M	7.49M	-2.97M	5.32M	3.17M	-0.57M	-2.10M	-17.04M	12.33M	5.88M	-21.59M	-12.20M	14.53M	40.76M	-56.16M
Additional items
EPS (Basic) (Quarter)	0.16	0.10	0.39	-0.01	0.07	0.00	0.06	-0.02	0.04	0.02	0.00	-0.02	-0.13	0.09	0.04	-0.17	-0.10	0.11	0.28	-0.44
EPS (Weighted Average and Diluted) (Quarter)	0.15	0.09	0.38	-0.01	0.07	0.00	0.06	-0.02	0.04	0.02	0.00	-0.02	-0.13	0.09	0.04	-0.17	-0.10	0.11	0.27	-0.44
Shares Outstanding (Weighted Average) (Quarter)	128.24M	128.55M	128.33M	128.79M	129.21M	130.90M	130.07M	131.08M	131.29M	131.31M	131.23M	131.86M	132.57M	132.34M	131.67M	126.30M	126.85M	126.68M	126.74M	127.80M
Shares Outstanding (Diluted Average) (Quarter)	133.72M	133.85M	133.66M	128.79M	132.60M	132.56M	132.38M	131.08M	132.48M	132.79M	132.75M	131.86M	132.57M	133.93M	131.67M	126.30M	133.93M	126.68M	130.25M	127.80M
EBITDA (Quarter)	23.59M	16.26M	19.75M	-0.13M	11.94M	1.78M	8.72M	-4.00M	9.74M	8.05M	-1.27M	-3.85M	-13.89M	6.24M	10.22M	-26.75M	-12.58M	20.73M	28.46M	-68.89M
Interest Expenses (Quarter)	2.43M	1.48M	0.85M	0.74M	0.73M	0.57M	-0.03M	0.65M	0.59M	0.44M	0.50M	0.51M	0.62M	0.47M	-0.06M	-0.96M	-0.67M	-0.41M	-0.24M	-0.38M
Tax Rate (Quarter)	2.30%	2.35%	-0.69%	-5.18%	21.82%	82.26%	14.48%	35.83%	42.09%	58.53%	68.37%	51.65%	-17.21%	-111.76%	25.16%	26.92%	20.64%	-1.92%	16.12%	22.37%

Research Tools

Organogenesis Holdings Income Statement (2015-2026) | ORGO

Create an account

Sign In

Reset Password